Company Encyclopedia
View More
name
TOUYUN BIOTECH
01332.HK
Touyun Biotech Group Limited, an investment holding company, designs, develops, manufactures, and sells packaging products in Hong Kong, the People’s Republic of China, Europe, North and South America, and internationally. The company operates through four segments: QR Code Business, Packaging Products Business, Treasury Investment Business, and Chlamydomonas Reinhardtii Products Business. The QR Code Business segment provides QR codes on product packaging and solutions, including made-to-order solutions. The Packaging Products Business segment manufactures and sells watch and jewelry boxes, eyewear cases, bags and pouches, and display units.
12.31 B
01332.HKMarket value -Rank by Market Cap -/-

Financial Score

11/11/2025 Update
D
Containers and PackagingIndustry
Industry Ranking14/20
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE60.21%A
    • Profit Margin-20.12%D
    • Gross Margin29.98%C
  • Growth ScoreC
    • Revenue YoY0.32%C
    • Net Profit YoY87.60%A
    • Total Assets YoY7.24%B
    • Net Assets YoY75.89%A
  • Cash ScoreD
    • Cash Flow Margin-497.00%E
    • OCF YoY0.32%C
  • Operating ScoreD
    • Turnover0.24D
  • Debt ScoreE
    • Gearing Ratio101.01%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Hong Kong Stock Movement: TOUYUN BIOTECH surges 21.95%, active capital inflow attracts market attention

    TOUYUN BIOTECH surged 21.95%; HSSP INTL fell 5.33%, with a transaction volume of HKD 1.36 million; JiaYao Holdings had a transaction volume of HKD 742,000; YiHe International Holdings fell 4.68%, with a transaction volume of HKD 9,720; Sunshine Paper's market value reached HKD 1.789 billion

    HK Stock Movers Tracker·
    HK
    01332
    +68.70%
    HK Stock Movers Tracker·
    HK
    01332
    +68.70%

    Hong Kong Stock Movement: TOUYUN BIOTECH plummets 20%, market concerns arise due to lack of formal agreement on strategic cooperation

    TOUYUN BIOTECH fell 20.00%; HSSP INTL rose 11.20%, with a transaction volume of HKD 9.14 million; Jia Yao Holdings fell 2.19%, with a transaction volume of HKD 806,600; TEAMWAY INTL GP rose 10.53%, with a transaction volume of HKD 391,800; Sunshine Paper's market value reached HKD 1.779 billion

    HK Stock Movers Tracker·
    HK
    01332
    +68.70%
    HK Stock Movers Tracker·
    HK
    01332
    +68.70%

    Understanding the Market | TOUYUN BIOTECH falls over 28% Company responds to stock price fluctuations Subsidiary signs a 1 billion yuan procurement framework agreement for Rhein algae

    TOUYUN BIOTECH's maximum cumulative increase over the previous three trading days was nearly 9 times. Today, the stock price fell by more than 28%, and as of the time of writing, it has dropped by 22%, trading at HKD 0.39, with a transaction volume of HKD 8.9506 million. In terms of news, TOUYUN BIOTECH issued a statement regarding the unusual fluctuations in stock price and trading volume, stating that its wholly-owned subsidiary Shanxi TOUYUN signed a strategic cooperation agreement on October 23 with Shenzhen Building Supply Chain Technology, Henan State-owned Marketing Management, and Beijing HeWanjia Biotechnology. According to this agreement, from 2026 to 2028, the sales consortium will purchase no less than RMB 1 billion worth of Rhodella and related products from Shanxi TOUYUN

    Zhitong·
    HK
    01332
    +68.70%
    Zhitong·
    HK
    01332
    +68.70%

    TOUYUN BIOTECH may procure no less than 1 billion RMB of Rhein algae and sign a strategic cooperation agreement

    TOUYUN BIOTECH has signed a strategic cooperation agreement with Henan Guozi Marketing and Beijing HeWanjia to procure no less than 1 billion RMB of Rhizoclonium from 2024 to 2028. The company noted the increase in stock price and trading volume but confirmed that it is unaware of the reasons for the recent stock price fluctuations and has no undisclosed insider information

    etnet·
    HK
    01332
    +68.70%
    etnet·
    HK
    01332
    +68.70%

    Touyun Biotech Announces Strategic Cooperation Amid Unusual Market Activity

    Touyun Biotech Group Limited (HK:1332) announced a strategic cooperation agreement to purchase Chlamydomonas reinhardtii products worth at least RMB1 billion from 2026 to 2028. This comes amid unusual market activity, with a significant increase in share price and trading volume. The company confirmed its operations remain normal. The latest analyst rating for the stock is a Hold with a price target of HK$0.50. The current market cap is HK$1.08B, with an average trading volume of 1,589,265.

    Tip Ranks·
    HK
    01332
    +68.70%
    Tip Ranks·
    HK
    01332
    +68.70%